Navigation Links
RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
Date:1/29/2008

ANAHEIM, Calif., Jan. 29 /PRNewswire-FirstCall/ -- RG Global (OTC Bulletin Board: RGBL) announced today that the company is on schedule for construction of its coal bed methane water treatment plant and discussed numerous projected growth areas for the Company.

Coal Bed Methane Water Treatment Plant On Schedule

RG Global's Catalyx Fluid Solutions (CFS) expects to complete construction by the end of February on its first plant employing the Catalyx Fluid Solutions ion exchange technology to treat water discharged during the harvesting of coal bed methane (CBM). Final commissioning of the plant should be completed by the end of March 2008. The plant, located in Wyoming, will remove excess sodium and other environmentally harmful minerals from the CBM-produced water as part of a previously announced five-year, $20-22 million gross revenue Build-Own-and-Operate contract with one of the largest CBM production companies in the U.S.

"Numerous energy production companies have expressed keen interest in our CFS technology and we are currently in negotiations for additional CBM water treatment plants in the U.S. and abroad," said Juzer Jangbarwala, RG Global CTO. "RG Global is in an excellent position to capitalize on the increased interest in coal bed methane as an unconventional fuel in many countries that are attempting to reduce their dependence on oil and coal."

Additional Water Treatment Applications

Water has been capturing headlines as an increasing valuable resource, particularly in drought-stricken areas and where there is widespread contamination in the water supply, causing skyrocketing demand for effective, cost-efficient water treatment technologies such as RG Global's CFS solution. CFS is in negotiations with multiple companies for additional applications of its ion exchange technology, which can be used to remove nitrates, arsenic, sodium and a wide variety of inorganic contaminants from water to make it suitable for h
'/>"/>

SOURCE RG Global Lifestyles, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
3. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
4. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
5. PPD Expands Global Central Lab Services into China
6. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
7. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. Jerusalem Global Ventures Announces $200 Million Growth Equity Fund
10. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
11. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...dge, Mass November 30, 2009 An international tea...otonics, and ETH Zrich have demonstrated compact, ... the invisible part of the light spectrum (infrare...t beam of a well-defined wavelength. The innovativ...ons related to remote chemical sensing pollution m...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Th...ch (MJFF) today announced $1.5 million in total aw...ntially disease-modifying therapies for Parkinson,...l Approaches to Drug Discovery for Parkinson,s Dis...Corporation, plc (NYSE: ELN ), a neuroscience-ba...
(Date:11/30/2009)..., AMSTERDAM, November 30 Biop...y that the first patients have been enrolled in it...TIR(TM). The study is,designed to show reduction i...r following an allogeneic stem cell transplantatio...od cancer patients eligible for an allogeneic,stem...
(Date:11/30/2009)..., ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ ...it has completed enrollment in the Phase II clinic.../2009 recommended strains) VLP vaccine candidate i...dults). This randomized, double-blind, active-con...y and immunogenicity of two different doses (15 mc...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4
...., Sept. 17 Diageo (NYSE: DEO ),the world,s lead...nounce,its sponsorship of a physician,s training p...ues developed by the Medical Society of the State ... by Diageo as an unrestricted grant, is,being deve...assess issues,related to alcohol abuse. This train...
...versity of the Year Announces Potential Breakthrou...titis C., CHICAGO, Sept. 17 The British Midlands...University of Nottingham in the,British Midlands h...of a,possible Hepatitis C Vaccine. The United Kin...tor,generating revenues in excess of $8.6 billion ...
...pt. 17 /PRNewswire-FirstCall/ - Angiotech Pharmace... today that it reached a favourable,agreement with...("Conor"),to settle all outstanding patent litigat...tent. "With this agreement now in place, Angiotec...d enforce our intellectual property should decreas...
Other Biology Technology:Diageo Sponsors Medical Society of the State of New York's Physicians Training Program 2Diageo Sponsors Medical Society of the State of New York's Physicians Training Program 3The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 2The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 2Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 3Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation 4
(Date:11/30/2009)...OUSTON (Nov. 30, 2009) Scientists and engineers f...ne and energy will come together Dec. 7 with lead...g oil and pumping blood. , Much like moving oil ...ugh the body. Both systems need clean, well-funct... or corrosion, to function efficiently. Both indus...
(Date:11/30/2009)...OBOKEN, N.J. - The inaugural Global Conference on... 3-4, 2009, in Washington, DC, focuses on the conv...ises of critical importance to society. , Th...f research activity around targeted complex system... year,s topic includes Critical Infrastructure Sys...
(Date:11/30/2009)...s global temperatures continue to rise scientists ...tanding how species respond and adapt. In a paper ...Dr Francisco Rodriguez-Trelles and Dr Miguel Rodri...global warming of approximately 0.6˚C has alr...challenge facing ecologists and evolutionary biolo...
Breaking Biology News(10 mins):Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2How can scientists measure evolutionary responses to climate change? 2Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 1Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 1Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 3Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 4Excalibur International Marine 2849 25 Owned by EFT BioTech Holdings 29 Completes Inaugural Passenger Crossing of Taiwan Strait 12858 1Excalibur International Marine 2849 25 Owned by EFT BioTech Holdings 29 Completes Inaugural Passenger Crossing of Taiwan Strait 12858 2Excalibur International Marine 2849 25 Owned by EFT BioTech Holdings 29 Completes Inaugural Passenger Crossing of Taiwan Strait 12858 3
...e than 25 years, stem cells have been defined base...well as multiple different specialized cell types....y powerful, many scientists have sought a more mol...s they express. , Now, a team of Canadian scienti...f a gene called Oct4 considered to be the master r...
...gix, Inc. (OTC Bulletin Board: NRGX) today announc...rnal The Lancet of positive results from the first...nd the first report of direct gene transfer into a...nerative disease. , The open label Phase 1 study,...s disease demonstrated both a lack of adverse even...
...esistance to a retrovirus that infected chimpanzee...ironically may be at least partially responsible f...oday. , These findings, reported by a team of rese...in the June 22 issue of Science, provide a better ...rough the study of an ancient virus called Pan tro...
Other Biology News:Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state 2Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 2Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 3Gene therapy study shows safety and statistically significant improvement in Parkinson's disease 4Ancient retrovirus sheds light on modern pandemic 2Ancient retrovirus sheds light on modern pandemic 3
Mouse Anti-Human Troponin I Monoclonal Antibody, Unconjugated, Clone 22B11 from Santa Cruz Biotechnology, Inc.
Immulon 4 HBX 1x12 Strip from Thermo Scientific
Nar I from Promega
...kinase (rEK) is a highly purified preparation of t...ine protease which recognizes the identical cleava...;) and has similar enzymatic activity. Novagen&'s ...eld the highest activity available, and is qualifi...
Biology Products: